159 related articles for article (PubMed ID: 21256847)
41. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.
Wormley FL; Heinrich G; Miller JL; Perfect JR; Cox GM
Infect Immun; 2005 Aug; 73(8):5022-30. PubMed ID: 16041017
[TBL] [Abstract][Full Text] [Related]
42. Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii.
Hamilton AJ; Holdom MD
Infect Immun; 1997 Feb; 65(2):488-94. PubMed ID: 9009302
[TBL] [Abstract][Full Text] [Related]
43. Biochemical and kinetic characterization of xylulose 5-phosphate/fructose 6-phosphate phosphoketolase 2 (Xfp2) from Cryptococcus neoformans.
Glenn K; Ingram-Smith C; Smith KS
Eukaryot Cell; 2014 May; 13(5):657-63. PubMed ID: 24659577
[TBL] [Abstract][Full Text] [Related]
44. Identification of C18:1-phytoceramide as the candidate lipid mediator for hydroxyurea resistance in yeast.
Matmati N; Metelli A; Tripathi K; Yan S; Mohanty BK; Hannun YA
J Biol Chem; 2013 Jun; 288(24):17272-84. PubMed ID: 23620586
[TBL] [Abstract][Full Text] [Related]
45. Unique subsite specificity and potential natural function of a chitosan deacetylase from the human pathogen
Hembach L; Bonin M; Gorzelanny C; Moerschbacher BM
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3551-3559. PubMed ID: 32015121
[No Abstract] [Full Text] [Related]
46. Inositol acylation of glycosylphosphatidylinositols in the pathogenic fungus Cryptococcus neoformans and the model yeast Saccharomyces cerevisiae.
Franzot SP; Doering TL
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):25-32. PubMed ID: 10229655
[TBL] [Abstract][Full Text] [Related]
47. GWT1 encoding an inositol acyltransferase homolog is required for laccase repression and stress resistance in the basidiomycete Cryptococcus neoformans.
Zhao Q; Wei D; Li Z; Wang Y; Zhu X; Zhu X
FEMS Yeast Res; 2015 Dec; 15(8):. PubMed ID: 26410852
[TBL] [Abstract][Full Text] [Related]
48. Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host.
O'Meara TR; Hay C; Price MS; Giles S; Alspaugh JA
Eukaryot Cell; 2010 Aug; 9(8):1193-202. PubMed ID: 20581290
[TBL] [Abstract][Full Text] [Related]
49. Functional analysis of ISC1 by site-directed mutagenesis.
Okamoto Y; Vaena de Avalos S; Hannun YA
Biochemistry; 2003 Jul; 42(25):7855-62. PubMed ID: 12820895
[TBL] [Abstract][Full Text] [Related]
50. Characterization of an immunogenic cellulase secreted by Cryptococcus pathogens.
Midiri A; Mancuso G; Lentini G; Famà A; Galbo R; Zummo S; Giardina M; De Gaetano GV; Teti G; Beninati C; Biondo C
Med Mycol; 2020 Nov; 58(8):1138-1148. PubMed ID: 32246714
[TBL] [Abstract][Full Text] [Related]
51. A beta-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases.
Klutts JS; Levery SB; Doering TL
J Biol Chem; 2007 Jun; 282(24):17890-9. PubMed ID: 17430900
[TBL] [Abstract][Full Text] [Related]
52. The Monothiol Glutaredoxin Grx4 Regulates Iron Homeostasis and Virulence in Cryptococcus neoformans.
Attarian R; Hu G; Sánchez-León E; Caza M; Croll D; Do E; Bach H; Missall T; Lodge J; Jung WH; Kronstad JW
mBio; 2018 Dec; 9(6):. PubMed ID: 30514787
[TBL] [Abstract][Full Text] [Related]
53. Sterol-Response Pathways Mediate Alkaline Survival in Diverse Fungi.
Brown HE; Telzrow CL; Saelens JW; Fernandes L; Alspaugh JA
mBio; 2020 Jun; 11(3):. PubMed ID: 32546619
[TBL] [Abstract][Full Text] [Related]
54. The role of laccase in prostaglandin production by Cryptococcus neoformans.
Erb-Downward JR; Noggle RM; Williamson PR; Huffnagle GB
Mol Microbiol; 2008 Jun; 68(6):1428-37. PubMed ID: 18410494
[TBL] [Abstract][Full Text] [Related]
55. Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase.
Mandala SM; Thornton RA; Milligan J; Rosenbach M; Garcia-Calvo M; Bull HG; Harris G; Abruzzo GK; Flattery AM; Gill CJ; Bartizal K; Dreikorn S; Kurtz MB
J Biol Chem; 1998 Jun; 273(24):14942-9. PubMed ID: 9614099
[TBL] [Abstract][Full Text] [Related]
56. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.
Ganendren R; Widmer F; Singhal V; Wilson C; Sorrell T; Wright L
Antimicrob Agents Chemother; 2004 May; 48(5):1561-9. PubMed ID: 15105106
[TBL] [Abstract][Full Text] [Related]
57. Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans.
Missall TA; Lodge JK
Eukaryot Cell; 2005 Feb; 4(2):487-9. PubMed ID: 15701811
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the antigenicity of Cpl1, a surface protein of Cryptococcus neoformans var. neoformans.
Cai JP; Liu LL; To KK; Lau CC; Woo PC; Lau SK; Guo YH; Ngan AH; Che XY; Yuen KY
Mycologia; 2015; 107(1):39-45. PubMed ID: 25261494
[TBL] [Abstract][Full Text] [Related]
59. Characterizing the role of RNA silencing components in Cryptococcus neoformans.
Janbon G; Maeng S; Yang DH; Ko YJ; Jung KW; Moyrand F; Floyd A; Heitman J; Bahn YS
Fungal Genet Biol; 2010 Dec; 47(12):1070-80. PubMed ID: 21067947
[TBL] [Abstract][Full Text] [Related]
60. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
